---
title: "SHARPS TECHNOLOGY INC C/WTS (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD 38.62"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/240445183.md"
datetime: "2025-05-15T20:10:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/240445183.md)
  - [en](https://longbridge.com/en/news/240445183.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/240445183.md)
generator: "portal-rs"
---

# SHARPS TECHNOLOGY INC C/WTS (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD 38.62

EPS: As of FY2025 Q1, the actual value is USD 38.62.

### Segment Revenue

-   The company has not generated any revenue to date.

### Operational Metrics

-   **Net Income (Loss)**: For the three months ended March 31, 2025, the company reported a net income of $1,928,834, compared to a net loss of - $982,386 for the same period in 2024.
-   **Research and Development Expenses**: Decreased to $82,016 in 2025 from $197,439 in 2024, a reduction of $115,423 or 58%.
-   **General and Administrative Expenses**: Increased to $1,939,753 in 2025 from $1,646,613 in 2024, an increase of $293,140 or 18%.

### Cash Flow

-   **Net Cash Used in Operating Activities**: - $2,450,564 for the three months ended March 31, 2025, compared to - $1,889,315 for the same period in 2024.
-   **Net Cash Used in Investing Activities**: - $473,658 in 2025, compared to - $2,852 in 2024.
-   **Net Cash Provided by Financing Activities**: $13,953,031 in 2025, compared to $396 in 2024.

### Unique Metrics

-   **Warrant Liability**: As of March 31, 2025, the warrant liability was $7,781,658, compared to $98,913 as of December 31, 2024.

### Future Outlook and Strategy

-   **Core Business Focus**: The company is committed to driving revenue growth from Securegard and Sologard projects in 2025, with production on track for a transition to revenue in the second half of 2025.
-   **Non-Core Business**: The company continues to work towards amending the Asset Purchase Agreement with Nephron and InjectEZ, LLC, with the closing contingent on obtaining further amendments and necessary financing.

### Related Stocks

- [STSSW.US](https://longbridge.com/en/quote/STSSW.US.md)
- [SKYAW.US](https://longbridge.com/en/quote/SKYAW.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**